New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
07:17 EDTMDCOThe Medicines Co. downgraded to Market Perform from Outperform at Leerink
Leerink downgraded The Medicines Co. to Market Perform citing uncertainty regarding Angiomax estimates into the appeals trial. The firm lowered its price target for shares to $27 from $30.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
06:55 EDTMDCOEagle Pharmaceuticals submits NDA for ready-to-use bivalirudin to FDA
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use